Actuate Therapeutics Common Stock Volatility Indicators True Range

ACTU Stock

2.84 -0.11 -3.73%

The volatility indicators view organizes True Range indicator and supporting indicators around Actuate Therapeutics. The analysis highlights volatility indicators and range-based signals and frames technical signals with volatility and risk context.

Symbol

Indicator

The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Actuate Therapeutics volatility developed by Welles Wilder.

Actuate Therapeutics Technical Analysis Modules

Most technical analysis of Actuate Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Actuate from various momentum indicators to cycle indicators. When you analyze Actuate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

About Actuate Therapeutics, Inc. Common stock

Actuate Therapeutics is publicly available via the NASDAQ Exchange. Downside history and drawdown behavior provide context for risk expectations in Actuate Therapeutics. Downside profile remains relatively contained. Actuate Therapeutics has market cap of 136.67 M.

Methodology

Unless otherwise specified, financial data for Actuate Therapeutics Common is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Actuate (USA Stocks:ACTU) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Actuate Therapeutics Common is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Jefferies, Raymond James, Goldman Sachs, Bank of America Securities, Morgan Stanley, among others. Updates may occur throughout the day.

Become your own money manager

Tracking Actuate Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio Optimization Now

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk

All Next

Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Macroaxis Index Invested few shares	Go
	FinTech Invested over 60 shares	Go
	Artificial Intelligence Invested few shares	Go
	Investor Favorites Invested over 200 shares	Go
	Dividend Beast Invested over 40 shares	Go
	Baby Boomer Prospects Invested over 20 shares	Go
	Driverless Cars Invested over 200 shares	Go
	Impulse Invested over 200 shares	Go
	Hedge Favorites Invested few shares	Go
	Social Domain Invested few shares	Go

Additional Tools for Actuate Stock Analysis

	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC